Порушення функціонального стану ендотелію у хворих на пептичну виразку шлунка та дванадцятипалої кишки, поєднану з метаболічним синдромом

Автор(и)

  • O. I. Fediv
  • I. O. Sitsinska

DOI:

https://doi.org/10.24061/2413-0737.XVII.1.65.2013.39

Ключові слова:

ендотеліальна дисфункція, пероксидне окиснення ліпідів, оксид азоту, метаболічний синдром, виразкова хвороба шлунка, дванадцятипала кишка, гіпертонічна хвороба, гіперглікемія

Анотація

В оглядовій статті узагальнено основні відомості про роль ендотеліальної дисфункції при пептичній виразці шлунка та дванадцятипалої кишки в процесі виникнення і становлення метаболічного синдрому. Наведено дані про вплив ендотеліальних чинників на розвиток ремоделювання судинної стінки при виразці шлунка і дванадцятипалої кишки та метаболічному синдромі.

Посилання

Serediuk NM. Hospital'na terapiia [Hospital therapy]. Kiev: Zdorov`ia; 2006. 315-19 p. (in Ukrainian).

Bondarenko TV. Osoblyvosti morfolohichnoho stanu slyzovoi obolonky shlunka u khvorykh na vyrazkovu khvorobu dvanadtsiatypaloi kyshky zalezhno vid naiavnosti ta patohennosti Helicobacter pylori [Features of the morphological state of the mucous membrane of the stomach in patients with ulcers of the duodenum, depending on the presence and pathogenicity of Helicobacter pylori]. Suchasna hastroenterolohiia. 2004;4:41-4 (in Ukrainian).

Vdovychenko VI. Vplyv duodenohastral'noho refleksu na efektyvnist' eradykatsii helikobakternoi infektsii u khvorykh na vyrazkovu khvorobu dvanadtsiatypaloi kyshky pry zastosuvanni potriinoi terapii [Influence of duodenogastric reflex on the effectiveness of eradication of helicobacter infection in patients with duodenal ulcer in the use of triple therapy]. Hastroenterolohiia. 2001;32:196-9. (in Ukrainian).

Horobets' NM, Sierkova VK. Stabil'ni metabolity oksydu azotu u khvorykh na arterial'nu hipertenziiu [Stable metabolites of nitric oxide in patients with arterial hypertension]. Ukrains'kyi terapevtychnyi zhurnal. 2005;2:22-4. (in Ukrainian).

Polivoda SN, Cherenok AA, Sychev RV. Korrektsiya endotelial'noy disfunktsii u bol'nykh gipertonicheskoy bolezn'yu: effektivnost' i patofiziologicheskoe obosnovanie primeneniya tiotriazolina [Correction of endothelial dysfunction in patients with essential hypertension: efficacy and pathophysiological justification for the use of thiotriazoline]. Aktual'ni pytannia farmatsevtychnoi ta medychnoi nauky ta praktyky. Zaporizhzhia; 2002. 193-6 p. (in Russian).

Hostyschev VK, Yevsieiev MA. Patohenez retsydyvu hostrykh hastroduodenal'nykh vyrazkovykh krovotech [Pathogenesis of relapse of acute gastroduodenal ulcer bleeding]. Khirurhiia. 2004;5:46-51. (in Ukrainian).

Abrahamovych OO, Fainyk AF, Nechai OV. Mekhanizmy rozvytku dysfunktsii endoteliiu ta yii rol' u patohenezi ishemichnoi khvoroby sertsia [Mechanisms of development of endothelium dysfunction and its role in the pathogenesis of coronary heart disease]. Ukrains'kyi kardiolohichnyi zhurnal. 2007;4:81-7. (in Ukrainian).

Ageev FT. Rol' endotelial'noy disfunktsii v razvitii i progressirovanii serdechno-sosudistykh zabolevaniy [The role of endothelial dysfunction in the development and progression of cardiovascular diseases]. Serdechnaya nedostatochnost'. 2003;1:22-5. (in Russian).

Almazov VA, Berkovich OA, Sytnikova MYu. Endotelial'naya disfunktsiya u bol'nykh s debyutom ishemicheskoy bolezni serdtsa v raznom vozraste [Endothelial dysfunction in patients with debut of coronary heart disease at different ages]. Kardiologiya. 2001;41(5):26-9. (in Russian).

Babak OYa, Shaposhnikova YuN, Nemtsova VD. Arterial'naya gipertenziya i ishemicheskaya bolezn' serdtsa – endotelial'naya disfunktsiya: sovremennoe sostoyanie voprosa [Arterial hypertension and ischemic heart disease - endothelial dysfunction: the current state of the issue]. Ukrains'kyi terapevtychnyi zhurnal. 2004;1:14-21. (in Russian).

Bilets'kyi SS. Endoteliiprotektorni vlastyvosti karvedylolu u khvorykh z hostrym infarktom miokarda [Endothelial-protective properties of carvedilol in patients with acute myocardial infarction]. Ukrains'kyi kardiolohichnyi zhurnal. 2007;2:81-4. (in Ukrainian).

Belenkov YuN, Mareev VYu, Ageev FT. Endotelial'naya disfunktsiya pri serdechnoy nedostatochnosti: vozmozhnosti terapii ingibitorami angiotenzinprevrashchayushchego fermenta [Endothelial dysfunction in heart failure: treatment options for angiotensin converting enzyme inhibitors]. Kardiologiya. 2001;41(5):100-4. (in Russian).

Vatutin NT, Kalinkina NV. Endoteliny i serdechno-sosudistaya patologiya [Endothelins and cardiovascular pathology]. Ukrains'kyi kardiolohichnyi zhurnal. 2006;1:101-6. (in Russian).

Vizir' VA, Berezin AE. Rol' endotelial'noy disfunktsii v formirovanii i progressirovanii arterial'noy gipertenzii. Prognosticheskoe znachenie i perspektivy lecheniya [The role of endothelial dysfunction in the formation and progression of arterial hypertension. Prognostic significance and prospects of treatment]. Ukrains'kyi medychnyi chasopys. 2004;4:23-33. (in Russian).

Gomazkov OA. Endotelii v kardiologii: molekulyarnye, fiziologicheskie i patologicheskie aspekty [Endothelium in cardiology: molecular, physiological and pathological aspects]. Kardiologiya. 2001;2:50-6. (in Russian).

Korkushko OV, Lishnevskaya VYu. Endotelial'naya disfunktsiya [Endothelial dysfunction]. Krovoobih ta hemostaz. 2003;2:4-15. (in Russian).

Mayanskaya SD, Kuimov AD. Endotelial'naya disfunktsiya i ostryy koronarnyy sindrom [Endothelial dysfunction and acute coronary syndrome]. Rossiyskiy kardiologicheskiy zhurnal. 2001;2(28):76-84. (in Russian).

Polivoda SN, Cherepok AA, Sychev RA. Vliyanie amlodipina na funktsiyu endoteliya u bol'nykh s gipertonicheskoy bolezn'yu: klinicheskie effekty i patofiziologicheskie mekhanizmy [Effect of amlodipine on endothelial function in patients with essential hypertension: clinical effects and pathophysiological mechanisms]. Ukrains'kyi kardiolohichnyi zhurnal. 2007;4:46-9. (in Russian).

Zateyshchikov DA, Manushkina LO, Kudryashova OYu. Polimorfizm genov NO-sintetazy i retseptora angiotenzina ІІ 1-go tipa i endotelial'nyy gemostaz u bol'nykh ishemicheskoy bolezn'yu serdtsa [Polymorphism of NO-synthetase and angiotensin II type 1 receptor genes and endothelial hemostasis in patients with coronary heart disease]. Kardiologiya. 2000;40(11):28-32. (in Russian).

Barbarash OL, Kashtalap VV, Karetnikova VN. Klinicheskaya znachimost' pokazateley endotelial'noy disfunktsii, oksidativnogo stressa i gemostaza u bol'nykh infarktom miokarda [Clinical significance of indices of endothelial dysfunction, oxidative stress and hemostasis in patients with myocardial infarction]. Patologiya krovoobrashcheniya i kardiokhirurgiya. 2007;2:28-33. (in Russian).

Bratus' VV. Oksid azota kak regulyator zashchitnykh i gomeostaticheskikh reaktsiy organizma [Nitric oxide as a regulator of protective and homeostatic reactions of the body]. Ukrains'kyi revmatolohichnyi zhurnal. 2003;4:3-11. (in Russian).

Lutai MI, Slobods'kyi VA, Havrylenko TI. Kontsentratsiia endotelinu-1 v plazmi krovi koreliuie z vyrazhenistiu klinichnykh proiaviv stabil'noi stenokardii napruzhennia [Concentration of endothelin-1 in blood plasma correlates with the severity of clinical manifestations of stable angina pectoris]. Ukrains'kyi medychnyi chasopys. 2004;4:105-8. (in Ukrainian).

Namakanov BA, Rasulov MM. Endotelial'naya disfunktsiya pri arterial'noy gipertenzii – faktor riska serdechno-sosudistykh oslozhneniy [Endothelial dysfunction with arterial hypertension is a risk factor for cardiovascular complications]. Kardiovaskulyarnaya terapiya i profilaktika. 2005;6:98-101. (in Russian).

Polupanov AG, Khalmatov AN, Cheskidova NB. Funktsiya endoteliya i I/D-polimorfizm gena angiotenzinprevrashchayushchego fermenta u bol'nykh essentsial'noy gipertenziey [Endothelial function and I/D polymorphism of the gene of the angiotensin-converting enzyme in patients with essential hypertension]. Kardiologiya. 2007;47(6):54-5. (in Russian).

Vasyliuk VM. Semiotyka ta diahnostyka vnutrishnikh khvorob. Fizychni metody obstezhennia [Semiotics and diagnostics of internal diseases. Physical examination methods]. 2nd ed. Ternopil: TDMU; 2005. 12-3 p. (in Ukrainian).

Solov'ev AI. Kletochnye mekhanizmy gipertenzii (arterial'naya gipertenziya kak endotelial'naya disfunktsiya i membrannaya kanalopatiya) [Cellular mechanisms of hypertension (arterial hypertension as endothelial dysfunction and membrane canalopathy)]. Likuvannia ta diahnostyka. 2002;1:9-13. (in Russian).

Syvolap VD, Syvolap VV. Uroven' endotelina-1 pri oslozhnennom techenii infarkta miokarda [The level of endothelin-1 in the complicated course of myocardial infarction]. Vrachebnoe delo. 2002;2:139-140. (in Russian).

Cherepok AA. Kliniko-prognosticheskoe znachenie endotelial'noy disfunktsii u bol'nykh gipertonicheskoy bolezn'yu [Clinical and prognostic value of endothelial dysfunction in patients with essential hypertension]. Ukrains'kyi medychnyi al'manakh. 2003;6(3):177-180. (in Russian).

Asselbergs FW, Boer RA, Diercks GF. Vascular endothelial growth factor: the link between cardiovascular risk factors and microalbuminuria? Int J Cardiol. 2004;93(2-3):211-5.

Ferrara N. Vascular endothelial growth factor: basic science and clinical progress. Endocrin Rev. 2004;25:581-611.

Das S, Mishra TK, Satpathy C. Endothelins and endothelin receptor antagonists. JIACM. 2004;5(1):55-9.

Pasceri V, Willerson JT. Direct proinflammatory effect of C-reactive on human endothelial cells. Circulation. 2000;102:2165-8.

O'Keefe JH, Wetzel M, Moe RR. Should an angiotensin-converting enzyme inhibitor be standard therapy for patients with atherosclerotic disease. JACC. 2001;37(1):1-8.

Neels JG, Thinnes T. Angiogenesis in an in vivo model of adipose tissue development. FASEB J. 2004;18:983-5.

Dimmeler F, Zeiher AM. Endothelial cells apoptosis in angiogenesis and vessel regression. Circulat Res. 2000;87:434-4.

Tsai WC, Li YH. Vascular endothelial growth factor as a marker for early vascular damage in hypertension. Clin Scin. 2005;109:39-43.

Gómez-Ambrosi J, Catalán V, Rodríguez A. Involvement of serum vascular endothelial growth factor family members in the development of obesity in mice and humans. J Nutr Biochem. 2010;21(8):774-80.

Gielen S, Erbs S, Schuler G. Exercise training and endothelial dysfunction in coronary artery disease and chronic heart failure. From molecular biology to clinical benefits. Minerva Cardioangiol. 2002;50:95-106.

Wada H, Ura S. Distinct characteristics of circulating vascular endothelial growth factors and C levels in human subjects. PLoS One. 2011;6:6.

Zorena K, Mys'liwska J, Mys'liwiec M. Association between vascular endothelial growth factor and hypertension in children and adolescents type I diabetes mellitus. J Hum Hypert. 2010;24:755-62.

Ayerden EF, Haksun E, Ulver DB. The relationship between vascular endothelial growth factor (vegf) and microalbuminuria in patients with essential hypertension. Inter Med. 2008;47:1511-6.

##submission.downloads##

Опубліковано

2013-02-02

Номер

Розділ

НАУКОВІ ОГЛЯДИ